Embleema Alternatives & Competitors
12 companies similar to Embleema — Regulatory-grade real-world data platform for registries, research teams, and pa...
Companies similar to Embleema
xCures
Right Patient, Right Treatment, Right Time.
Aster Insights
Accelerating oncology medical product discovery and development through our scientific and...
Sano Genetics
Accelerating the world's transition to precision medicine.
Human Data Sciences
Experts in real-world evidence generation. Delivering intelligence in minutes and studies...
Rival Readout
Competing with Embleema? We do this properly.
10 rivals, 90 days of dated moves, ranked by what matters and sourced, in 7 business days.
CorEvitas, LLC
Regulatory grade real-world evidence and clinical insights on post approval safety and eff...
Precision Digital Health, Inc
Digital Trials and Connected Devices ... Simplified.
Sanguine Biosciences
Bridging the gap between researchers and patients
Truveta
Saving Lives with Data
AllStripes (now PicnicHealth)
Unlocking new treatments for people with rare disease
Franklin by QIAGEN
Franklin harnesses the power of its community to enable actionable insights, serving profe...
Character Biosciences
A patient-driven drug discovery platform for diseases of aging
About Embleema
Embleema, founded in 2017, is a cutting-edge player in the Biotechnology and Health Care industries. Headquartered in the United States, the company offers a regulatory-grade real-world data platform specifically designed for registries, research teams, and patient-driven discoveries. The platform is renowned for its a...
Unification of Multimodal Patient Data, Real-Time Data Capture, Audit-Ready Database Management, Protocol Configuration Without Coding, Patient and Site App Integration, Data Enrichment from EMRs and Wearables
Pharmaceutical Sponsors, Clinical Research Organizations, Healthcare Research Sites, Patients Participating in Clinical Trials
Regulatory-Grade Evidence, Real World Data, Genomics, Bioinformatics, Precision Medicine, Patient Engagement, Consent Management, Disease Registries, Clinical Trials, Electronic Data Capture, Rheumatology, Neurology, Cell And Gene Therapies, Patient-Driven Discovery, Observational Research
Platform, SaaS, B2B2C
Subscription, Usage Based, Service Fee
Frequently Asked Questions
From the desk
Mapping a market? Start with a Rival Readout.
In 7 business days we read 10 rivals around Embleema: 90 days of dated moves, ranked by what matters to you, each with its source. Fully credited if you continue.
Compiled from the BounceWatch company index. We last looked at Embleema on 3 Apr 2026. The 12 companies listed here were last checked between 12 Sep 2024 and 15 Jun 2026. Where a field is blank here, it means we have not recorded it — not that the answer is zero. How we source and date this.